Cristiano Franzi is Senior Vice President & President Baxter EMEA.
Cristiano holds a bachelor’s degree in marketing from The American University, an MBA from George Washington University, and completed an executive education program at Harvard Business School.
His experience spans over 20 years in the international healthcare market with proven track record in both large multinational and new venture environments.
Prior to his current role, Cristiano served as President, Minimally Invasive Therapies Group, EMEA, for Medtronic following its acquisition of Covidien, where he had served as President, Europe, for Covidien. While at Covidien, Cristiano also held several leadership roles across a broad range of therapeutic areas, functions and European geographies. Prior to Covidien, Cristiano served in commercial positions at ev3, Boston Scientific/SciMed and Becton Dickinson.
